76 related articles for article (PubMed ID: 3810973)
1. [Cytostatic treatment of metastatic adenocarcinoma and anaplastic carcinoma of unknown primary origin].
Aabo K; Rørth M; Hansen HH
Ugeskr Laeger; 1987 Jan; 149(2):80-1. PubMed ID: 3810973
[No Abstract] [Full Text] [Related]
2. Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.
Taal BG; Veenhof CH; Blijham GH; Neijt JP
Neth J Med; 1988 Apr; 32(3-4):204-11. PubMed ID: 3283582
[No Abstract] [Full Text] [Related]
3. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
[TBL] [Abstract][Full Text] [Related]
4. [The chemotherapy of metastases of unknown origin].
Shparyk IaV; Bilyns'kyĭ VT
Lik Sprava; 1996; (1-2):45-52. PubMed ID: 9005104
[No Abstract] [Full Text] [Related]
5. [A successful combination therapy with resection and infusion chemotherapy for a patient with metastases from cancer of unknown origin].
Nakagawa Y; Todoroki T; Koike N; Kawamoto T
Gan To Kagaku Ryoho; 2003 Mar; 30(3):423-6. PubMed ID: 12669405
[TBL] [Abstract][Full Text] [Related]
6. Management of carcinoma of unknown primary site (CUP), any changes?
Hansen HH; Daugaard G
Ann Oncol; 2001 Apr; 12(4):431-2. PubMed ID: 11398871
[No Abstract] [Full Text] [Related]
7. One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-101-S19-105. PubMed ID: 9427278
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic carcinoma of unknown origin].
Fizazi K; Culine S
Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
[TBL] [Abstract][Full Text] [Related]
9. [Surprisingly positive effect of palliative CAP chemotherapy of bone-disseminated, undifferentiated carcinoma of unknown primary origin in patient with low performance status according to WHO].
Swiatoniowski G; Bruzewicz S; Suder E; Warszylewicz-Szymanek M; Kłaniewski T; Prudlak E; Molenda W; Setta M
Przegl Lek; 2006; 63(3):166-8. PubMed ID: 16969902
[TBL] [Abstract][Full Text] [Related]
10. [The CUP syndrome--malignant disease with unknown primary tumor. Part 4: Therapy and prognosis].
Jaspersen D
Fortschr Med; 1992 Nov; 110(31):587-8. PubMed ID: 1478594
[No Abstract] [Full Text] [Related]
11. Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients.
Alberts AS; Falkson G; Falkson HC; van der Merwe MP
Med Pediatr Oncol; 1989; 17(3):188-92. PubMed ID: 2747591
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of unknown primary site.
Greco FA; Burris HA; Erland JB; Gray JR; Kalman LA; Schreeder MT; Hainsworth JD
Cancer; 2000 Dec; 89(12):2655-60. PubMed ID: 11135228
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203
[TBL] [Abstract][Full Text] [Related]
14. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
17. [Metastatic occult primary cancer].
Aabo K
Ugeskr Laeger; 1987 Jan; 149(2):76-9. PubMed ID: 3544422
[No Abstract] [Full Text] [Related]
18. Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets.
Pavlidis N
Ann Oncol; 2012 Sep; 23 Suppl 10():x282-5. PubMed ID: 22987978
[TBL] [Abstract][Full Text] [Related]
19. Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Polyzos A; Koulentianos E; Tzianoumis L; Sfikakis P
J Chemother; 1989 Jul; 1(4 Suppl):1185-6. PubMed ID: 16312826
[No Abstract] [Full Text] [Related]
20. [A case of squamous cell carcinoma of unknown primary site with involvement of cervico-mediastinal lymph nodes successfully treated by chemoradiotherapy].
Watanabe S; Tanaka J; Tsuboi K; Tanaka H; Kagamu H; Yoshizawa H; Suzuki E; Gejyo F
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1493-5. PubMed ID: 17033245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
